Patients with HbA@c levels of @ % to @ % ( @ to @ mmol/mol ) while receiving metformin ( @,@ mg/day ) were randomized and treated with once-daily treatment with empagliflozin @ mg ( n = @ ) , empagliflozin @ mg ( n = @ ) , or placebo ( n = @ ) for @ weeks .